Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heme and Tin Mesoporphyrin in Acute Porphyrias
NCT00004396Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Sep 1997
- Modality
- Orthosteric Ligands, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label trial of stannsoporfin in acute intermittent porphyria (AIP) (2 arms), sponsored by National Center for Research Resources. Primary endpoints: Lowering of porphyrin precursors and Safety and tolerability. Started Sep 1997; status: completed.
02
Drugs
stannsoporfin
03
Conditions
acute intermittent porphyria (AIP)
Beyond the preview
Go deeper on NCT00004396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004396.